🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the efficacy of tumescent solution on ...
Status
Completed
Location
Pgids Rohtak
Start Date
2025-03-23
Trial ID
NCT07436546
There are several local anesthetic techniques available for cataract surger...
Status
Completed
Location
Kasr Alaini Hospital
Start Date
2015-05-01
Trial ID
NCT03243500
To evaluate the use of recombinant hyaluronidase (rHuPH20) as an adjunctive...
Status
Withdrawn
Location
Duke Eye Center
Start Date
TBD
Trial ID
NCT02059694
Treatments Being Tested
To compare the effect of the used local anesthetics in this study on decrea...
Status
Completed
Location
Research Institute of Ophthalmology
Start Date
2022-02-22
Trial ID
NCT05728151
Treatments Being Tested
This study aims to compare the efficacy of ketorolac and fentanyl as adjuva...
Status
Recruiting
Location
Cairo University
Start Date
2024-08-25
Trial ID
NCT07141589
50 patients of both sexes, ages 18 to 75, who were scheduled for cataract s...
Status
Completed
Location
Suez canal university
Start Date
2023-12-01
Trial ID
NCT06784843
The aim of this study is to calculate the minimum effective volume of local...
Status
Completed
Location
Faculty of Medicine ,Ain Shams University
Start Date
2019-07-31
Trial ID
NCT04036201
Treatments Being Tested
Nowadays, a number of cases with increased intraocular pressure and glaucom...
Status
Unknown
Location
Cairo University
Start Date
2016-08
Trial ID
NCT02846090
Treatments Being Tested
Nalbuphine has been used as an adjuvant to bupivacaine in intrathecal, epid...
Status
Completed
Location
Ahmed Abdalla Mohamed
Start Date
2018-01-14
Trial ID
NCT03436836
To evaluate the effects of adding magnesium sulfate to atracurium with loca...
Status
Recruiting
Location
Dalia yousry mohamed
Start Date
2023-02-01
Trial ID
NCT06600945
Treatments Being Tested